More than Target, Kroger, and Foot Locker, which stocks are experiencing the largest price changes during the midday trading session?

Check out the companies making headlines in midday trading.

Despite supply chain pressures, Target's shares rose 9.9% after reporting 9% sales growth in the fiscal fourth quarter. The company expects to maintain this momentum and has projected revenue growth in the low to mid-single digits, as well as a rise in adjusted earnings per share by high single digits in the year ahead.

Kroger's stock price increased by 3.3% following Telsey's upgrade of the grocery store chain prior to its earnings release. According to Joseph Feldman of Telsey, "We have greater insight and assurance into Kroger's long-term growth potential in the omni-channel sector."

Goldman Sachs downgraded Foot Locker's stock to neutral from buy, citing near-term pressure on the stock, after the athletic retailer announced it would sell fewer Nike products.

Despite AutoZone's earnings and revenue beating expectations for its fiscal second quarter, and a 13.8% increase in same-store sales year over year, the retail stock still dipped 2.5%.

Workday's quarterly earnings results exceeded expectations, causing its shares to rise 4.9%. Additionally, the company forecasted its fiscal year 2023 subscription revenue to be between $5.53 billion and $5.55 billion, representing a 22% year-over-year increase.

The electric car manufacturer's shares dropped 13.8% in midday trading after reporting a larger-than-anticipated loss of 64 cents per share, while analysts had predicted a loss of 25 cents per share. Additionally, revenue was $26.4 million, which was lower than the forecasted $36.7 million.

Zoom's shares dropped 7.4% following the release of weaker-than-anticipated first quarter and full-year guidance, despite the company surpassing earnings and revenue expectations in the fourth quarter.

Novavax's shares increased by 2.7% during the day, but only rose by 0.4% at closing. Despite reporting a miss on both the top and bottom lines in the fourth quarter, the biotech company anticipates revenue between $4 billion and $5 billion in 2022. Additionally, Novavax is currently working on an omicron-specific vaccine.

Despite J.M. Smucker's better-than-expected earnings report, its shares fell 6.3%. The company also reduced its fiscal-year sales growth guidance and the high end of its fiscal-year earnings guidance.

Hormel earnings surpassed Wall Street expectations, causing a 4% increase in its stock share price.

After Wells Fargo reaffirmed its equal-weight rating on Rivian stock, the shares dropped 8.4%, with the firm citing "too many near-term headwinds."

After Bank of America reiterated its buy rating on Chevron stock, the shares increased by 4%. This occurred following Chevron's announcement that it was near acquiring Renewable Energy Group.

On Tuesday, financial stocks experienced significant losses, with Bank of America declining 3.9% and Wells Fargo falling 5.8%. The drop in Treasury yields and the ongoing conflict in Eastern Europe, as well as the sanctions on Russia, have caused some traders to worry about the impact on credit markets.

As U.S. crude reached its highest level since June 2014, energy stocks experienced a rise, with Occidental Petroleum gaining 7% and APA Corp increasing by 4.6%.

As investors monitored increasing tension in the Russia-Ukraine conflict, defense stocks gained, with Lockheed Martin rising 5.3% and Northrop Grumman adding 3.2%.

Maggie Fitzgerald, Jesse Pound, and Samantha Subin of CNBC provided reporting.